QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Quantify’s Douglas Knutsson interviewed by Life-time
Quantify’s Douglas Knutsson was interviewed by Life-time for having mapped the availability of 116 new medicines approved by the EMA in 2017-2019, on behalf of Lif – de forskande läkemedelsföretagen. The study covered not only the rate of availability and time to market but also factors affecting these parameters, an assessment of replaceability of non-available medicines and characteristics of medicines that were […]
Quantify supports nonprofit organization Majblomman
Everyone is affected by the ongoing pandemic, especially the most vulnerable of us. Therefore, Quantify has decided to make a donation to Majblomman, a nonprofit organisation with the mission to decrease the impact of child poverty in Sweden.
Majblomman’s work is usually financed by thousands of children that sell “majblomman” – a small flower pin – each year in April. This year […]
Findings from Nordic RWE study BISCUITS
Quantify’s Sara Hallberg, Emilie Toresson Grip & Johan Liseth Hansen are participating authors on the poster presenting one of the most comprehensive Nordic RWE studies on the economic burden of osteoarthritis conducted to date.
The BISCUITS study presented at ISPOREurope found people with osteoarthritis incurred over 60% the average annual costs compared to people without OA, including costs of primary care, productivity loss, specialist care and drugs. Learn more from […]
Lead Analyst Christoph Abé joins Quantify
Last week we got to welcome another superstar to the team – Christoph Abé, our new Lead Analyst. Christoph has a PhD in biophysics and many years of experience within health care, psychiatry, and clinical research. He will strengthen our crew as a problem solver with a broad scientific knowledge in data analysis, statistics, programming, and neuroscience.
Quantify Research provides high quality and real-world evidence-based research services, which are essential […]